Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
about
Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular PathologyDual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.Conformationally Strained trans-Cyclooctene (sTCO) Enables the Rapid Construction of (18)F-PET Probes via Tetrazine LigationATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction in Minipigs.Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.Peptide-based imaging agents for cancer detection.RGD PET: From Lesion Detection to Therapy Response Monitoring.Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model.Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Optical Surgical Navigation for Precision in Tumor Resections.Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.Multimodality Imaging in Tumor Angiogenesis: Present Status and PerspectivesExploring the Role of RGD-Recognizing Integrins in Cancer.Imaging of Integrin αvβ3 Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer 99mTc-IDA-D-[c(RGDfK)]2Dendrimer-based contrast agents for PET imaging.Stability assessment of a new antithrombotic small peptide, Arg-Gly-Asp-Trp-Arg (RGDWR), and its derivative.High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging αv β3 Integrin.The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses.Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination.Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different 68Ge/68Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans.Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer Screening.Angiogenesis PET Tracer Uptake (68Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs.Monitoring of tumor vascular normalization: the key points from basic research to clinical application
P2860
Q26747500-ABFFE2EA-E332-4C88-895A-52E0B876A29AQ30362004-1BB8E290-7D58-46EE-A6E1-40027F5B33BDQ33588257-2E7FAEC8-5581-4E58-AA62-E65AD9208DD8Q36228314-93EE75E8-2EDC-43D1-906F-3D6658F44603Q36882982-8FEF3A54-2D76-4E7D-BCBA-7C76C2184F36Q36926032-8DDD62B7-3452-4437-B6E6-0DD7D2AD77EBQ37061453-65877B08-FEB9-4F09-9681-C3A5221B0B23Q37389699-A760FCBD-6562-47AD-8F42-CA6B6DCDE5B1Q37393139-1A6D340A-5941-40D1-ABBB-BDD360244884Q37585965-51AD1627-09A8-49B5-AA35-53AD0DD744F7Q37591171-E134BD8A-D5B5-4B70-8C11-83C9F3027A22Q38718291-BBE980D1-FCDB-4841-BA09-904EF4833B13Q38729299-0308EF55-D142-43EE-9E49-4EE4C53DF28AQ38976861-F66B848F-DA5F-4413-B414-636826DAF224Q39016753-FD2C5093-8944-4D5B-ACC0-CC7ECD5181FDQ39167489-47BCAFEE-C6AB-49D1-ACFF-021A45FF6F34Q41415544-B33FA2C3-FBBC-4D16-AF7B-4F4CC996DC66Q41661199-40EA0761-A397-42E3-BC78-5052A1283155Q41670915-B2DFED93-9199-4128-943B-9C6803F38EF8Q42602933-C4971826-073F-48ED-8B35-DFD29EFE632DQ47362426-21916D23-4E5D-42F8-A0F1-86B6B0A99C1AQ48154617-529C5249-2F0F-4D0A-A9F1-42065001AFB3Q48285145-54CCB436-DF6B-4859-BCC9-61015B28A173Q49165125-516EC341-290A-4AF9-9768-DC88BEF61D0BQ51251756-EBD6F374-012E-4FEA-8A37-653CD0002315Q51771438-F128085F-C44F-4DEC-A1D8-51EB1EC99D74Q52562051-56146895-C7AF-4101-A6DD-E55EAB62FF97Q55714408-87208BAA-7D15-42AD-BCAE-E59FE80817DAQ57484416-CA301B40-38D2-4A73-9450-A67940F46812
P2860
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@ast
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@en
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@nl
type
label
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@ast
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@en
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@nl
prefLabel
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@ast
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@en
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@nl
P2860
P921
P3181
P356
P1433
P1476
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
@en
P2093
P2860
P3181
P356
10.7150/THNO.13242
P407
P577
2016-01-01T00:00:00Z